Bråten Lars Christian Haugli, Grøvle Lars, Wigemyr Monica, Wilhelmsen Maja, Gjefsen Elisabeth, Espeland Ansgar, Haugen Anne Julsrud, Skouen Jan Sture, Brox Jens Ivar, Zwart John-Anker, Storheim Kjersti, Ostelo Raymond Wjg, Grotle Margreth
Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital HF, Ulleval, Bygg 37b, Postbox 4956, Nydalen, 0424, Oslo, Norway.
Department of Rheumatology, Østfold Hospital Trust, PB 300, 1714, Grålum, Norway.
J Clin Epidemiol. 2022 Nov;151:75-87. doi: 10.1016/j.jclinepi.2022.07.012. Epub 2022 Aug 1.
The objective of this study was to estimate the minimal important change (MIC) and responsiveness of core patient reported outcome measures for chronic low back pain (LBP) and Modic changes.
In the Antibiotics in Modic changes (AIM) trial we measured disability (RMDQ, ODI), LBP intensity (NRS) and health-related quality of life (EQ5D) electronically at baseline, three- and 12-month follow-up. MICs were estimated using Receiver Operating Curve (ROC) curve and Predictive modeling analyses against the global perceived effect. Credibility of the estimates was assessed by a standardized set of criteria. Responsiveness was assessed by a construct and criterion approach according to COSMIN guidelines.
The MIC estimates of RMDQ, ODI and NRS scores varied between a 15-40% reduction, depending on including "slightly improved" in the definition of MIC or not. The MIC estimates for EQ5D were lower. The credibility of the estimates was moderate. For responsiveness, five out of six hypotheses were confirmed and AUC was >0.7 for all PROMs.
When evaluated in a clinical trial of patients with chronic LBP and Modic changes, MIC thresholds for all PROMs were on the lower spectrum of previous estimates, varying depending on the definition of MIC. Responsiveness was sufficient.
本研究的目的是评估慢性下腰痛(LBP)及Modic改变的核心患者报告结局指标的最小重要变化(MIC)和反应性。
在Modic改变中的抗生素(AIM)试验中,我们在基线、3个月和12个月随访时通过电子方式测量了残疾程度(RMDQ、ODI)、LBP强度(NRS)和健康相关生活质量(EQ5D)。使用接受者操作特征曲线(ROC)和针对整体感知效应的预测模型分析来估计MIC。通过一套标准化标准评估估计值的可信度。根据COSMIN指南,采用结构和标准方法评估反应性。
RMDQ、ODI和NRS评分的MIC估计值在降低15%至40%之间变化,这取决于MIC定义中是否包括“稍有改善”。EQ5D的MIC估计值较低。估计值的可信度为中等。对于反应性,六个假设中有五个得到证实,所有患者报告结局指标的曲线下面积(AUC)均>0.7。
在慢性LBP和Modic改变患者的临床试验中进行评估时,所有患者报告结局指标的MIC阈值处于先前估计范围的下限,具体取决于MIC的定义。反应性足够。